Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (127 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 13 Oct 2014 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Aditya Birla Sun Life Aggressive Hybrid Omni FOF |
|---|---|
| 13 Oct 2014 | ₹100.00 |
| 09 Oct 2015 | ₹110.63 |
| 04 Oct 2016 | ₹124.06 |
| 29 Sep 2017 | ₹135.89 |
| 25 Sep 2018 | ₹140.73 |
| 21 Sep 2019 | ₹146.95 |
| 16 Sep 2020 | ₹161.55 |
| 11 Sep 2021 | ₹206.68 |
| 07 Sep 2022 | ₹213.96 |
| 03 Sep 2023 | ₹242.95 |
| 29 Aug 2024 | ₹307.44 |
| 24 Aug 2025 | ₹321.13 |
| 20 Aug 2026 | ₹339.27 |
| Metric | Aditya Birla Sun Life · Direct · IDCW NAV ₹43.36 Very High risk ★★★☆☆ | Category median FoF Domestic · 127 funds |
|---|---|---|
| +5.28% | +6.09% | |
| +12.53% | +11.54% | |
| +11.06% | +7.95% | |
| +10.83% | +9.85% | |
| +10.86% | +8.39% | |
| +11.15% | — | |
| +11.38% | +11.20% | |
| +11.32% | +9.48% | |
| +11.23% | +10.18% | |
| Risk | ||
| 8.98% | 12.96% | |
| 0.67 | 0.43 | |
| 0.91 | 0.62 | |
| -17.30% | -17.91% | |
| Nifty 500 | — | |
| +1.76% | +0.56% | |
| 0.64 | 0.95 | |
| 74.7% | 95.5% | |
| 54.4% | 86.6% | |
| 0.56% | 0.14% | |
| ₹41.18Cr | ₹338.76Cr | |
| — | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 6% | 14% | |
| Vinod Bhat · 7y | — | |
| 13 Oct 2014 | — | |
| — | — | |
| — | — | |
| 0.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.